ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $5.21M invested in Enlivex Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$64.4K
2
+$40K
3
+$27K
4
OC
Oppenheimer & Co
New York
+$13.5K
5
TRCT
Tower Research Capital (TRC)
New York
+$6K

Top Sellers

1
-$600
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.27M
2
$1.31M
3
$305K
4
$140K
5
$108K
6
$40K
7
$27K
8
$6K
9
$4K
10
$2K
11
$1K
12
$1K